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Legionella pneumophila is a facultative intracellular bacterial pathogen (1) and
the agent of Legionnaires' disease, a serious and often fatal form of pneumonia.
The organism is spread to humans from contaminated sources by the airborne
route. Patients with Legionnaires' disease develop both humoral and cell-medi-
ated immune responses (2-4). Humoral immune responses appear to play a
secondary role in host defense because antibody does not promote killing of L.
pneumophila by complement, promotes only modest killing of L. pneumophila by
phagocytes (polymorphonuclear leukocytes, monocytes, or alveolar macro-
phages), and does not inhibit intracellular multiplication in monocytes. Cell-
mediated immune responses appear to play a primary role in host defense because
activated monocytes and alveolar macrophages inhibit L. pneumophila intracel-
lular multiplication (4-6).
The guinea pig, which shares with humans a susceptibility to lung infection
with L. pneumophila, is an excellent animal model for the study of Legionnaires'
disease (7-11). When guinea pigs are exposed to aerosols containing L. pneumo-
phila, they develop, after an incubation period of a few days, a pneumonic illness
characterized by fever, weight loss, and labored respirations that sometimes
culminates in death. This syndrome strongly resembles Legionnaires' disease in
humans both clinically and pathologically (7-9).
Sublethal exposure of guinea pigs to L. pneumophila has not been demonstrated
to result in protective immunity to lethal challenge with this organism in previous
studies. Two studies reported no protection against lethal challenge after suble-
thal exposure (12, 13). This seemed surprising in view of what was known about
host defense against this organism .
In this study, we have evaluated the immune responses of the guinea pig to
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sublethal aerosol exposure with L. pneumophila and examined the protective
effects of such exposure. We shall demonstrate that guinea pigs sublethally
infected with L. pneumophila by aerosol (a) develop humoral immune responses,
(b) develop cell-mediated immune responses and cutaneous delayed-type hyper-
sensitivity, (c) are protected against subsequent lethal aerosol challenge with L.
pneumophila, and (d) are able to limit L. pneumophila multiplication when chal-
lenged and to clear the bacteria from their lungs.
Materials and Methods
Media. RPMI 1640 with L-glutamine (Gibco Laboratories, Grand Island, NY), eg
yolk buffer (EYB)' with (EYB-BSA) or without 1 % BSA, and Dulbecco's PBS with Ca
and Mg` ions were obtained or prepared as described previously (1, 14).
Agar.
￿
Modified charcoal yeast extract (CYE) agar was prepared as described (1).
Bacteria.
￿
L. pneumophila, Philadelphia I strain, was grown in embryonated hens' eggs,
harvested, tested for viability and the presence of contaminating bacteria, as described
(1), passed one time only on CYE agar, washed with EYB, flash frozen in aliquots of 10"
CFU/ml, and stored at -70° C. Before use in the aerosol inoculation system, each stock
preparation was diluted in EYB to the desired concentration. Formalin-killed L. pneumo-
phila was prepared as previously described (4).
Animals.
￿
Male Hartley strain guinea pigs weighing 250-300 g, purchased from Charles
River Breeding Laboratories (North Wilmington, MA), were housed three to a stainless
steel cage and allowed free access to ascorbic acid-fortified chow and water before the
experiment. They were observed in the vivarium for signs of illness for ^-1 wk before
each experiment to ensure that they were healthy at the start of the experiment. After
they were exposed to aerosols, the guinea pigs were kept in filter top cages for I wk. They
were observed for signs of illness, their rectal temperatures were taken with a Tele-
thermometer with rectal probe (Yellow Springs Instrument Co., Yellow Springs, OH),
and their weights were recorded daily. They were allowed free access to chow and water
throughout the experiment.
AerosolInoculation System.
￿
This system was constructed with the guidance and generous
assistance of Paul Edelstein (Wadsworth Veterans Administration Medical Center, Los
Angeles, CA). The aerosol chamber was constructed of lucite and measured 13 X 24 X
18 in. On opposite sides it had two 6-in-diam portals for introducing or removing guinea
pigs; these sealed tightly during aerosolization. The aerosol inlet was located at the center
of the chamber ceiling; it was connected to a Dart aerosol nebulizer system (Dart
Industries, Ocala, FL). A vacuum pump (Gast Mfg. Co., Benton Harbor, MI) delivered
positive pressure to the nebulizer and applied negative pressure to the chamber via a
small outlet valve. Although the chamber was self-contained, it was placed within a laminar
flow hood during aerosolization as an extra measure of safety. Guinea pigs were placed
inside of the chamber and 10 ml of a suspension of L. pneumophila or control buffer was
placed in the nebulizer reservoir. The vacuum pump was then turned on, generating an
aerosol into the chamber. Aerosolization was allowed to continue for 30 min or until the
nebulizer was empty (whichevercame first). The pump was then turned offand the guinea
pigs were held within the device for 10 min. The animals were then removed and placed
in filter top cages, one to three to a cage. When shared, cages contained only guinea pigs
that had been exposed to the same concentration ofL. pneumophila.
The number of CFU of L. pneumophila in the lungs of guinea pigs after exposure to
aerosols was only a small fraction of the number aerosolized. In two experiments, four
guinea pigs exposed to an aerosol of 108 CFU/ml had an average of 2.0 X 109 CFU in
their lungs I h later.
Serology.
￿
Antibody against L. pneumophila in the serum of selected guinea pigs was
determined by the indirect fluorescent antibody (IFAb) technique as described for human
' Abbreviations used in this paper:
￿
CYE, modified charcoal yeast extract; EYB, egg yolk buffer;
IFAb, indirect fluorescent antibody.BREIMAN AND HORWITZ
￿
801
serum by Wilkinson et al. (15). Antigen-bearing slide wells were prepared by covering
each well of a 12-well microscope slide (Cel-Line Associates, Minotola, NJ) with 30 Al of
a 2 X 109 cells/ml preparation of formalin-killed L. pneumophila, allowing the slides to air
dry, fixing the slides in acetone for 15 min, and again allowing the slides to air dry. Serum
was obtained from the animals by cardiac puncture just before sacrifice, serially diluted
in an equal volume of PBS up to a concentration of 1 :1,024, and placed on an antigen-
bearing slide well. The slides were incubated at 37 °C in 100% humidity for 30 min,
rinsed in PBS, and soaked in a PBS bath for 10 min. Then, 20,ul of fluorescein-conjugated
IgG fraction goat anti-guinea pig IgG (Fc fragment) (Cappel Laboratories, Cochranville,
PA) was placed on each well, and the slides were incubated at 37°C in 100% humidity
for 30 min and rinsed. The slides were viewed at X 1,000 with a fluorescence microscope
(Nikon Inc., Garden City, NY). The titer of each animal's serum was expressed as the
reciprocal of the dilution which produced 2+ fluorescence staining of at least 50% of the
L. pneumophila bacteria in a microscopic field.
Cutaneous Delayed-type Hypersensitivity.
￿
Guinea pigs were shaved over the back and
flank and given intradermal injections at different sites in this area of various concentra-
tions of formalin-killed L. pneumophila diluted in 0.1 ml of PBS. The diameter of areas of
erythema and induration at the site of the injection was recorded at 24 and 48 h.
Lymphocyte Proliferation Assay.
￿
Guinea pigs were killed by hypercarbia. The bodies
were soaked in Linbro 7X cleaning solution (Flow Laboratories, Inc., McClean, VA) and
the spleens were removed using sterile technique. Spleens were placed in RPMI 1640
with penicillin (100 U/ml) and streptomycin (100 ug/ml) (Gibco) and ground to a pulp.
The pulp was strained through a thin layer of nylon mesh to remove fibrous material,
and the spleen cellsin the liquid passing through the mesh were collected by centrifugation
at 200 g for 10 min at 4°C. Residual erythrocytes were hypotonically lysed and isotonicity
was restored as described (16). The remaining splenic lymphocytes were washed by
centrifugation and counted in a hemocytometer. For the lymphocyte proliferation assay,
the lymphocytes were adjusted to a final concentration of 10'/ml in RPMI 1640 containing
penicillin (100 U/ml), streptomycin, (100 ug/ml), and 10% FCS and incubated with
various concentrations of formalin-killed L. pneumophila as antigen in a total volume of
100 ul in microtest wells (96-well flat-bottom tissue culture plate, Falcon Labware, Oxnard,
CA). As controls, some lymphocytes were incubated without antigen, and others were
incubated with Con A. The lymphocytes were incubated at 37 ° C in 5% C02/95% air for
1-5 d. At the end of this incubation period, 0.25 ACi of [sH]thymidine (New England
Nuclear, Boston, MA) was added to each well and the cells were incubated at 37 ° C in 5%
C02/95% air for 2 h . Using a multisample automated cell harvester (Skatron, Inc.,
Sterling, VA), each well was washed with double-distilled water and the effluent was
passed through a filtermat. Filtermat sections representing separate microtest wells were
placed in scintillation vials and 2 ml of biofluor liquid scintillation cocktail (New England
Nuclear) was added. Afterat least 24 h, the beta particle emission was measured in a beta
scintillation counter (Beckman Instruments, Inc., Fullerton, CA).
Determination ofLowest Lethal Dose (LD).
￿
L. pneumophila, prepared as described above,
was diluted in EYB to concentrations of 106, 107, 5 X 10', 7.5 X 10", 108, 2 .5 X 108, 5 X
108, and 109 CFU/ml. Groups of animals were exposed in the aerosol delivery system to
aerosolized 10-ml aliquots of each of these concentrations of L. pneumophila . Over the
subsequent week, the rectal temperature, weight, and any physical signs of illness such as
lethargy, ruffled fur, labored respiration, grunting and deathwere recorded daily on each
animal.
Quantitation ofL. pneumophila in Pulmonary Tissue.
￿
In two independent experiments,
five guinea pigs were immunized in the aerosol delivery system with 0.01 LD of L.
pneumophila and five additional guinea pigs were exposed to buffer (controls). 28 d later,
all animals were exposed simultaneously to an aerosolized dose of 108 CFU/ml of L.
pneumophila. One immunized and one control guinea pig were then killed at 1, 6, 24, 48,
and 72 h after exposure. The animals were soaked in Linbro 7X cleaning solution (Flow
Laboratories, Inc.) and the right lung was removed from each animal using sterile
technique. Each lung was placed in 10 ml of sterile EYB and ground up with a mortar802
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TABLE I
Fatality Rate of Guinea Pigs Administered Various Concentrations of
L. pneumophila by Aerosol
Guinea pigs were infected with aerosols containing the concentration of
L. pneumophila indicated and the fatality rate at each concentration was
determined,
and pestle. The suspension from each animal was cultured on CYE agar and CYE agar
without cysteine (to rule out tfie presence of contaminating bacteria) as described (1).
Results
Aerosol Infection of Guinea Pigs with L. pneumophila.
￿
We exposed guinea pigs
to various concentrations (10'-109 CFU/ml) of live virulent L. pneumophila by
aerosol and observed them for signs of infection. Animals exposed to ?106
CFU/ml consistently had fever with temperatures >_40 °C 2-5 d after infection.
Animals exposed to >5 X 10' CFU/ml consistently displayed weight loss during
this period. Animals given a lethal dose exhibited labored respirations, grunting,
lethargy, ruffled fur, and shivering before death, which occurred 2-9 d after
exposure, depending on dose. At necropsy, on gross examination, the lungs were
hemorrhagic and congested or mottled withwhitish yellow areasofconsolidation.
L. pneumophila was isolated in high concentrations from the lung and spleen,
and also from the pericardium when pericardial effusion was present.
To determine the LD of L. pneumophila, defined here as the lowest concentra-
tion of L. pneumophila that was lethal to the majority of guinea pigs, we exposed
guinea pigs to various concentrations of aerosolized L. pneumophila in several
experiments and determined the rates of survival. Results were highly consistent
from one experiment to the next. Animals exposed to aerosols containing <10'
CFU/ml, infrequently died (Table I). In animals exposed to 108 CFU/ml, five of
seven animals died; the two surviving animals exhibited typical premorbid signs
of marked weight loss, labored respirations, and cyanotic extremities but they
survived. Animals exposed to >_2.5 X 108 CFU/ml all died (Table I). In view of
these results, we defined the LD in this model as 108 CFU/ml. In subsequent
experiments, all eight guinea pigs given 108 CFU/ml died; taken together with
the previous data, this indicates that this dose is very near the LDIOO for this
system .
Guinea Pigs Exposed to Sublethal Concentrations of Aerosolized L. pneumophila
Develop Humoral Immune Responses to the Bacterium. To determine whether
guinea pigs exposed to sublethal concentrations of aerosolized L. pneumophila
develop humoral immune responses, we measured the antibody titer to L.
pneumophila of sera from these and control animals by the IFAb assay. Exposed
Concentration ofL. pneumophila in
aerosol
CFU/ml
Number of guinea pigs dead
(per total exposed)
5 X 10' 1/5
7.5 X 10' 0/3
1 x 108 5/7
2.5 X 108 3/3
5 x 101, 5/5BREIMAN AND HORWITZ
￿
803
64F**Oft
8 M
0 4
￿
0
2
I
￿
O
<1 0
￿
0000
Sublethally Infected
￿
control
Guinea Pigs
￿
Guinea Pigs
FIGURE 1 .
￿
Guinea pigs sublethally infected with L. pneumophila develop a humoral immune
response. Reciprocal IFAb titers in the serum of sublethally infected (solid circles) and control
(open circles) guinea pigs were determined by the IFAb assay as described in the text.
animals but not controls developed significant antibody titers (Fig. 1). The
median IFAb titer, expressed as the reciprocal of the highest positive dilution,
from exposed guinea pigs was 32. Titers of control animals from <1 (negative
with undiluted serum) to 4; the median titer was <1 .
Guinea Pigs Exposed to Sublethal Concentrations of Aerosolized L. pneumophila
Develop Cutaneous Delayed-type Hypersensitivity. To study cutaneous delayed-
type hypersensitivity, we immunized guinea pigs with 10' to 10' CFU/ml of
aerosolized L. pneumophila and 2 wk later, we assayed the response of these and
control (nonimmunized) animals to intradermal injections of formalin-killed L.
pneumophila in concentrations ranging from 105 to 10I° bacterial particles/ml
(Table 11, Exp. A).
Immunized animals had markedly greater areas of erythema and induration
than control animals at both 24 and 48 h. Differences between immunized and
control animals were particularly significant at 24 h with antigen concentrations
of 107 and 10' formalin-killed L. pneumophila/ml: at 108 formalin-killed L.
pneumophila/ml, immunized animals had 9.6 ± 2.4 mm oferythema and 7.3 ±
2.3 mm ofinduration, whereas controls had only 2.5 ± 2.5 mm oferythema and
0 mm of induration. At 107 formalin-killed L. pneumophila/ml, immunized
animals had 7.8 ± 3.1 mm oferythema and 6.8 ± 3.2 mm ofinduration, whereas
controls had 0 mm oferythema and induration .
In a second experiment, we immunized four guinea pigs with an aerosolized
concentration of >_106 CFU of L. pneumophila/ml and skin-tested these and
control animals 1 mo later with antigen concentrations of 107 and 108 formalin-
killed L. pneumophila/ml (Table II, Exp. B). Again, immunized animals had
markedly greater areas oferythema and induration at both 24 and 48 h to both
antigen concentrations. Differences between immunized and control animals
were particularly significant with an antigen dose of 107 formalin-killed L.
pneumophila/ml. At 24 h, immunized animals exhibited 8.5 ± 2.7 mm of
erythema and 5.8 ± 3.6 mm ofinduration, whereas control animals had 0 mm
of erythema and 2 ± 2.8 mm of induration. At 48 h, immunized animals had
7.8 mm oferythema and 7.8 mm of induration, whereas controls had 0 mm of
erythema and induration.804
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TABLE II
Skin Reactivity ofSublethally Infected and Control Guinea Pigs to Intradermal Formalin-killed
L. pneumophila
A
B
Extent oferythema and induration in response to indicated antigen concen-
Exp.
Guinea pigs were sublethally infected with L. pneumophila, and 2 (Exp. A) or 4 (Exp. B) wk later, they and control guinea pigs were
skin-tested with formalin-killed L. pneumophila, as described in the text. Data given as means ±SD.
Splenic Lymphocytesfrom Guinea Pigs Recoveredfrom a Sublethal Infection with L.
pneumophila Proliferate in Response to L. pneumophila Antigens. To determine
whether immunized guinea pigs expand a population of lymphocytes that rec-
ognize L. pneumophila antigens, we studied the proliferative response of splenic
lymphocytes from these animals to formalin-killed L. pneumophila. In preliminary
experiments, we studied the proliferative responses of splenic lymphocytes that
were incubated with formalin-killed L. pneumophila for various incubation times
(1-7 d) and at various concentrations of lymphocytes per milliliter. We obtained
maximal responses when lymphocytes were at a concentration of 107 cells/ml
and incubated with antigen for 2 d. We therefore used this concentration of
lymphocytes and this incubation time in subsequent experiments.
Splenic lymphocytes from immunized guinea pigs consistently proliferated
strongly in response to L. pneumophila antigens in comparison to splenic lympho-
cytes from control animals at antigen concentrations of 106 to 108 formalin-
killed L. pneumophila/ml (Table III). Differences betweenimmunizedand control
animals were most significant for antigen concentrations of 107 and 10' bacterial
particles/ml . At 107 bacterial particles/ml, the mean determination for immu-
nized animals was 7,727 ± 1,590 cpm (SE), whereas the mean determination for
control animals was 2,397 ± 430 cpm; stimulation indices for immunized and
control animals were 6.8 ± 1 .2 and 1 .7 ± 0.1, respectively. At 108 bacterial
particles/ml, the mean determination forimmunizedanimals was 15,957 ± 2,700
Time
h
Status of guinea
pigs
n Skin reaction trations (bacterial particles/tai)
-
1019 109 l08 to, to, to,
mm
24 Immunized 8 Erythema 9.1 ±5.6 9.0 ±3.6 9.6 ±2.4 7.8 ± 3.1 3.5 ± 3.9 3.5 ±3.6
Induration 9.5±4.1 3.9±3.4 7.3±2.3 6.8±3.2 0±0 2.4±3.2
Control 2 Erythema 0 ±0 4 ±4 2.5 ±2.5 0 ± 0 0 ±0 0 ±0
Induration 6±1 0±0 0±0 0±0 0±0 0±0
48 Immunized 8 Erythema 7.1 ±4.2 5.8 ±4.6 5.6 ±5.9 3.5 ± 3.8 0.9 ± 2.3 1.4 ±2.4
Induration 10.5 ±2.2 7.3 ±6.0 7.5 ± 3.8 4.6 ± 4.7 0.6 ± 1.7 0 ±0
Control 2 Erythema 5.5 ±5.5 0 ±0 0 ±0 0 ± 0 0 ±0 0 ±0
Induration 6±6 0±0 0±0 0±0 0±0 0±0
Extent oferythema and induration in response to indicated antigen concen-
trations(bacterial particles/ml) at:
24h 48h
107 109 10, 108
Immunized 4 Erythema
MM
8.5 ±2.7 9.5± 1.7 7.8 ±2.2 10.0 ± 1.6
Induration 5.8 ±3.6 10.0 ± 1.2 7.8 ±2.2 10.3 ±2.5
Control 3 Erythema 0 ±0 2.0 ± 2.3 0 ±0 0 ±0
Induration 2.0 ±2.8 3.3 ± 4.7 0 ±0 6.3 ± 4.5TABLE III
Proliferation ofSplenicLymphocytesfrom Sublethally Infected and Control Guinea Pigs in
Response to Formalin-killed L. PneumophilaAntigens
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In each of five independent experiments (A-E), proliferation of splenic lymphocytes from one to three immunizedanimalsand one
control animal was studied. Splenic lymphocytes (107cells/ml) were incubatedin microtest wellsat 37°C for 2 d without antigen or
with formalin-killedL . pneumophila in concentrations of 106-10' bacterial particles/ml . The lymphocyteswere then assayed for their
capacity to incorporate [sH]thymidine as described in the text; foreach animal, the mean cpm t SEM for three or four microtest
wells is reported. At each antigen concentration, differences between Sl of control and immunized guinea pigs are significant at
p = 0.02 by a two-tailed t test.
* Sl, stimulation index = (mean [sH]thymidine incorporation (cpm) of lymphocytes incubated with antigen)/(mean ['H]thymidine
incorporation (cpm)of lymphocytes incubated without antigen).
cpm, whereas the mean determination for control animals was 5,993 ± 2,700;
stimulation indices for immunized and control animals were 14.4 ± 1.8 and 5.8
± 0.9, respectively.
Antigen concentrations of 109bacterial particles/ml yielded strong prolifera-
tive responses in both immunized and control animals, and antigen concentra-
tions of 10' ° bacterial particles/ml yielded background levels of proliferation in
all animals (data not shown) .
Guinea Pigs Recoveredfrom Sublethal Aerosol Infection with L. pneumophila Are
Protected against Lethal Aerosol Challenge. To determine whether guinea pigs
immunized by exposure to sublethal concentrations of L. pneumophila are pro-
tected against lethal challenge, we performed two large rechallenge experiments.
In the first experiment, 33 guinea pigs were divided into three equal groups and
exposed to EYB alone (control guinea pigs), 0.1 LD (107 CFU of L. pneumo-
phila/ml), or 0.01 LD (106 CFU of L. pneumophila/ml). Fever of >40°C devel-
oped in all guinea pigs exposed to L. pneumophila by day 2 (21 guinea pigs) or
day 3 (one guinea pig) and in none of the control animals. Weight loss occurred
[sH]Thymidine incorporation by splenic lymphocytes incubated with L. pneumophila antigens at
concentration (bacterial particles/ml)
indicated
Immu-
nized
No antigen IOs 10 7 lo,
Exp.
guinea
pigs
cpm cpm SI* cpm sI cpm si
A A, 1,619* 85 2,411 t 130 1.5 5,880 t 94 5.4 - -
B B, 1,271 t 75 1,975 t 36 1.6 6,606 t 270 5.2 14,933 t 650 11 .7
B2 485 t 55 1,249 t 29 2.6 2,879 t 110 5.9 6,707 t 200 13 .8
B3 938 t 50 4,291 t 270 4.6 14,908 t 1,020 15 .9 20,265 t 570 21 .6
C C, 1,022 t 67 3,953 t 154 3.9 8,500 t 260 8.3 22,418 t 470 21 .9
C4 457 t 15 583 t 15 1.3 1,092 t 81 2.4 3,816 t 63 8.3
D D, 1,532 :t: 37 2,061 t 89 1.4 3,908 t 60 2.6 11,139 t 220 7.3
D 2 937 t 45 2,412 t 120 2.6 6,146 t 280 6.6 19,204 t 400 20 .5
E E, 3,041 t 530 12,096 t 910 4.0 18,187 t 780 6.0 31,887 t 3,400 10 .5
Es 994 t 74 3,998 t 830 4.0 9,160 t 260 9.2 13,807 t 1,100 13 .9
Mean 1,230 t 222 3,503 t 976 2.8 t 0.4 7,727 t 1590 6.8 t 1.2 15,957 t 2,700 14 .4 t 1.6
Control
guinea
pigs
A A2 3,028 t 170 2,555 t 120 0.8 3,460 t 170 1.1 - -
8 B 4 630 t 38 812 t 12 1 .3 1,125 t 96 1.8 2,772 t 160 4 .4
C C3 901 t 76 1,083 t 60 1 .2 1,453 t 32 1 .6 3,891 t 270 4.3
D D3 1,334 t 64 1,049 t 250 0.8 2,558 t 260 1.9 7,577 t 2,050 5.7
E Es 1,772 t 83 2,377 t 83 1 .3 3,388 t 180 1.9 15,725 t 580 8.9
Mean 1,532 t 380 1,555 t 320 1.1 t 0 .1 2,397 t 430 1.7 t 0.1 5,993 t 2,700 5.8 t 0.9806 PROTECTIVE IMMUNITY AGAINST LEGIONELLA PNEUMOPHILA
TABLE IV
Survival Rates ofImmunized and Control Guinea Pigs Administered a Lethal Aerosol
ChallengeofL. pneumophila
Number of guinea pigs surviving
Guinea pigs initiallywere immunized with a sublethal dose of L. pneumophila (0.1 or 0.01 LD) or
exposedto an aerosol containing buffer alone (controls). 28 dlater, theanimalswere challenged
with 1, 3, or 10 LD andthenumber ofsurvivors wasdetermined. Differences between immunized
and control animals were evaluated by Fisher exact test, two-tailed. Differences between all
immunized and control guinea pigs challenged with 1 or 3 LD significant in experiment 1 at p<
0.0001 and in experiment 2 at p < 0.00005. Differences between all immunized and all control
guinea pigs challenged with 1, 3, or 10 LD, significant in Exp. 1 at p < 0.005 and in Exp. 2 at p
<0.00001.
* One control andone immunized animal were challenged with buffer alonein Exp. 1.
$ 2 of 11 animalsin this groupdied after receiving the 0.1-LDimmunizing dose.
p< 0.02
~p<0.02
' p< 0.01
**p<0.01
in 6 of 11 guinea pigs in the 0.01 LD group, in 8 of 11 in the 0.1 LD group,
and in 0 of 11 in the control group. Death occurred in two guinea pigs both in
the 0.1 LD group, 3 and 12 d after exposure . 1 mo after the first exposure, we
challenged the animals with either 1, 3, or 10 LD of L. pneumophila (Table IV).
In animals given one LD, none ofthree control guinea pigs survived, but all six
guinea pigs that had been sublethally infected with 0.1 or 0.01 LD survived.
The three-LD challenge yielded the same results; i.e., none of three control
guinea pigs and six of six sublethally infected guinea pigs survived. The 10-LD
challenge was lethal for all guinea pigs in all three groups. As an additional
experimental control, we exposed two guinea pigs (one in the control group and
one in the group given 0.01 LD) to EYB alone in the rechallenge part of the
experiment; as expected, both survived .
To confirm these results, we performed a second experiment in which we
initially exposed 15 guinea pigs to 0.01 LD aerosolized L. pneumophila and 15
guinea pigs to aerosolized EYB alone (control guinea pigs). 15 of 15 guinea pigs
exposed to L. pneumophila had temperatures >40°C by day 2 or 3, where 0 of
15 control guinea pigs had elevated temperatures. 11 of 15 guinea pigs exposed
to L. pneumophila had some weight loss as did 6 of 15 controls. No guinea pig
manifested ruffled fur or labored respirations. 1 mo after the first exposure, we
exposed these animals to 1, 3, or 10 LD of aerosolized L. pneumophila as in the
previous experiment (Table IV); 0 of 10 control animals survived challenge with
one or three LD, whereas 10 of 10 immunized animals survived these doses.
(per number challenged at indicated
Exp. Statusp off guinea Immunizing dose
LD
n
Buffer
alone*
dose
1
[LD])
3 10
1 Control Buffer alone 11 1/1 0/9 0/31 0/4
Immunized 0.1 9$ 0/0 3/34 3/31 0/3
0.01 11 1/1 3/3 3/3 0/4
2 Control Buffer alone 15 - 0/5' 0/5** 0/5
Immunized 0.01 15 - 5/5' 5/5** 2/5BREIMAN AND HORWITZ
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With the 10-LD challenge, none of five control animals survived, whereas two
of five immunized animals survived. Interestingly, in these experiments, guinea
pigs in the immunized groups but not control groups had fever on the first day
after challenge. In the first experiment, all 12 immunized guinea pigs had
temperatures of>40°C (mean 40.7 ± 0.36) on the first day after one- or three-
LD challenge, whereas none of six control guinea pigs had a temperature of
>40°C (mean 39.2 ± 0.45) after the same challenge. Similarly, in the second
experiment, 14 of 15 immunized guinea pigs had fever on the first day after
challenge (mean 40.6 ± 0.46), whereas 0 of the 15 control animals was febrile
(mean 39.12 ± 0.46). The fever in immunized animals was transientandsubsided
often by the second day after challenge. In the first experiment, for example,
only 1 of 10 guinea pigs (temperature could not be taken in 2) was febrile on
the second day after challenge.
Guinea pigs in both the immunized and control groups lost weight after
challenge. In the first experiment, 10 of 12 immunized animals and 6 of 6
control animals exhibited weight loss after challenge with one of three LD. In
the second experiment, all immunized and control animals displayed weight loss
to challenge with these doses.
Guinea pigs in both the immunized and control groups exhibited other signs
ofillness in response to challenge with one or three LD, although the frequency
was higher in the control group. The most frequently observed sign was labored
respirations; this occurred in 7 of 12 immunized animals and 6 of 6 controls.
Ruffled fur was observed in 1 of 12 immunized animals and 3 of 6 controls.
Immunized Guinea Pigs Limit L. pneumophila Multiplication and Clear L. pneu-
mophilafrom TheirLungs. To determine thefateofL. pneumophila inimmunized
guinea pigs, we challenged five guinea pigs recovered from sublethal infection
(0.01 LD) and five control guinea pigs with a one-LD aerosol, killed them 1-72
h later, and determined CFU ofL. pneumophila in their right lung. We performed
two independent experiments (Fig. 2). At 1 and 6 h after aerosol exposure,
immunized and control guinea pigs had comparable numbers of CFU of L.
pneumophila in their lungs in both experiments. By 24 h, the number of CFU
markedly increased in both the immunized and control animals tested although
the immunized animals had fewer bacteria (0.5 log fewer in the first experiment
and 1.5 log fewer in the second experiment). Thereafter, CFU in control animals
increased further to 4 logs above the 1-h level of infection, whereas CFU in
immunized animals decreased in both experiments. At 72 h, CFU in the immu-
nized animals had fallen to approximately the 1-h level of infection which was
4.5 log below the level in the control guinea pigs at this time point in both
experiments; in the first experiment, the control guinea pig died before necropsy
at 72 h.
Discussion
We have demonstrated that sublethal infection with L. pneumophila produced
protective immunity in vivo against this intracellular pathogen. Moreover, we
have demonstrated that sublethal infection with L. pneumophila by the airborne
route, the natural route of infection, protects against lethal challenge by this808
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FIGURE 2.
￿
Immunized guinea pigs clear L. pneumophila from their lungs when challenged
with a lethal dose. In two independent experiments (A and B), immunized and control guinea
pigs were challenged with a lethal dose of L. pneumophila and sacrificed 1-72 h later. CFU of
L. pneumophila in the right lung of each guinea pig was determined as described in the text.
Each point represents the mean ± SEM of two independent measurements from the same
lung sample.
route of infection. The development ofprotective immunity parallels the devel-
opment of humoral and cell-mediated immune responses.
Previous studies have failed to demonstrate protective immunity to L. pneu-
mophila in vivo (12, 13). We believe this is because the challenge doses in those
studies were so high that they overwhelmed the capacity of the immune system
to counteract the challenge. In our study, sublethally infected guinea pigs were
protected against one or three times the lowest lethal dose that killed nearly all
guinea pigs (-LD,oo), but these animals were not protected against 10 times that
dose. In the study by Baskerville et al. (12), sublethally infected guinea pigs were
challenged with 10 times the LD5o and not protected. In the study by Eisenstein
et al. (13), guinea pigs surviving a previous infection were challenged with 44
times the LD5o and were not protected.
In terms of lethality, the challenge doses we used, one and three times the
^-LD,oo, were still very high in comparison to the doses encountered by humans
in epidemics of Legionnaires' disease. In most epidemics, the fatality rate has
been ^-15% in untreated cases. This dose would be roughly equivalent to 0.1
LD in our system, i.e., 1/30 the highest challenge dose used. Thus, the protective
immunity induced by sublethal infection is very strong.
Immunized animals but not controls exhibited pyrexia on the first day after
challenge. This likely reflects an early inflammatory response to L. pneumophila
in the immunized animals. In the study by Baskerville et al. (12), immunized
guinea pigs challenged with 10 times the LD5o died sooner than controls, even
though the bacterial counts in the immunized animals were less than that of
controls. It is possible that an early inflammatory response coming immediately
after an overwhelming challenge resulted in the more rapid demise of these
animals.BREIMAN AND HORWITZ
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Cutaneous delayed-type hypersensitivity to L. pneumophila antigens developed
in guinea pigs immunized by the aerosol route in our study. Cutaneous hyper-
sensitivity to L. pneumophila antigens has previously been shown by Wong et al.
(17) to develop in guinea pigs immunized by the intraperitoneal route with L.
pneumophila and by the intradermal and intraperitoneal route with L. pneumo-
phila antigens.
Lymphocyte proliferation to L. pneumophila antigens in vitro was also demon-
strated in our study with splenic lymphocytes obtained from guinea pigs suble-
thally infected by the aerosol route. Splenic lymphocytes proliferated markedly
1-5 mo after guinea pigs were exposed to aerosols.
The right lungs ofboth immunized and control animals contained comparable
numbers of bacteria immediately after exposure to a lethal concentration of L.
pneumophila. In both the immunized and control animals, CFU did not signifi-
cantly change between 1 and 6 h after aerosolization; this parallels in vitro data
that L. pneumophila multiplication does not take place for the first few hours
after infection of mononuclear phagocytes during which time a specialized
ribosome-lined vacuole is formed (18). Between 6 and 24 h, CFU multiplied
logarithmically in both control and immunized animals. However, between 24
and 48 h, bacterial CFU continued to increase logarithmically in the control
animal but decreased in the immunized animal. This suggests that immune
protective forces were marshalled and became effective during the first 24 h
after exposure in the immunized animals. This may reflect the time required for
the development of the activated state in mononuclear phagocytes exposed to
lymphokines; such activated mononuclear phagocytes strongly inhibit L. pneu-
mophila intracellular multiplication (4-6).
Since Legionnaires' disease is transmitted by the airborne route, aerosol
infection ofguinea pigswith L. pneumophila mimics thenaturalroute ofinfection.
Because the disease in guinea pigs closely resembles the disease in humans
clinically and pathologically, aerosol infection ofguinea pigs with L. pneumophila
constitutesa superb animal model ofLegionnaires' disease. As a number ofother
diseases of the lung are caused by intracellular pathogens that are transmitted
by the airborne route (e.g., tuberculosis, psittacosis, Qfever, histoplasmosis, and
tularemia), this model may also serve as an excellent one for studying general
principles of host defense against lung infections caused by intracellular patho-
gens.
Summary
We have employed the guinea pig model of L. pneumophila infection, which
mimics Legionnaires' disease in humans both clinically and pathologically, to
study humoral and cell-mediated immune responses to L. pneumophila and to
examine protective immunity after aerosol exposure, the natural route of infec-
tion. Guinea pigs exposedto sublethal concentrations ofL.pneumophila by aerosol
developed strong humoral immune responses. By the indirect fluorescent anti-
body assay, exposed guinea pigs had a median serum antibody titer (expressed
as the reciprocal of the highest positive dilution) of 32, whereas control guinea
pigs had a median titer of<1. Sublethally infected (immunized) guinea pigs also
developed strong cell-mediated immune responses. In response to L. pneumophila810
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antigens, splenic lymphocytes from immunized but not control animals prolifer-
ated strongly in vitro, as measured by their capacity to incorporate [3H]thymi-
dine . Moreover, immunized but not control guinea pigs developed strong cuta-
neous delayed-type hypersensitivity to intradermally injected L. pneumophila
antigens.
Sublethally infected (immunized) guinea pigs exhibited strong protective im-
munity to L. pneumophila. In two independent experiments, all 22 immunized
guinea pigs survived aerosol challenge with one or three times the lethal dose of
L. pneumophila whereas none of 16 sham-immunized control guinea pigs survived
(p < 0.0001 in each experiment). Immunized guinea pigs were not protected
significantly from challenge with 10 times the lethal dose. Immunized but not
control animals cleared the bacteria from their lungs.
This study demonstrates that guinea pigs sublethally infected with L. pneumo-
phila by the aerosol route (a) develop strong humoral immune responses to this
pathogen, (b) develop strong cell-mediated immune responses and cutaneous
delayed-type hypersensitivity to L. pneumophila antigens, (c) are protected against
subsequent lethal aerosol challenge, and (d) are able to clear the bacteria from
their lungs. The guinea pig model of L. pneumophila pulmonary infection is as
an excellent one for studying general principles of host defense against pulmo-
nary infections caused by intracellular pathogens.
We are grateful to Dr. Paul Edelstein for his advice and assistance in the use of the guinea
pig model and to Ms. Barbara Jane Dillon and Ms. Debora S . Gloria for their generous
technical help.
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